Press Release

Boston, MA - Capstone Partners LLC, a national middle-market investment banking advisory firm, announced today that it has successfully advised Radius Medical Technologies, Inc. in a strategic transaction with an undisclosed leader in the medical device technology industry. The transaction will extend Radius Technologies’ established capabilities as a premier manufacturer of highly engineered guidewire products to the medical technology sector.

The transaction is a continuation of Capstone’s investment banking relationship with Radius, which dates back to 2004 when Capstone divested certain technology assets of Radius to Medtronic, Inc. (NYSE: MDT).  Capstone is currently serving as Radius’ ongoing investment banking advisor across various internal initiatives and alliances.  With respect to the most recently closed strategic transaction, Capstone managed the transaction process, acted as financial advisor, and assisted in the negotiations on behalf of Radius Medical Technologies, Inc. The terms of this transaction were not disclosed.

John Ferrara, Capstone’s president and managing partner, commented, “Radius has always been a market leader in the medical segments it serves.  We were happy to get this transaction completed on their behalf so that they can begin to focus on some of their new and exciting technology developments.”  He added, “This transaction was great timing for our Medical Device Group, which is currently in the market with five other transactions.  The med-tech market has remained extremely vibrant and we are very bullish on the next 12 to 24 months.” 

Radius Medical Technologies, Inc. is a privately held corporation based in Acton, MA, specializing in the design, development and marketing of minimally invasive medical devices for treating cardiovascular disease. For more information, visit www.radiusmed.com.